ASKA Pharmaceutical Holdings Co Ltd (4886)

Currency in JPY
2,498.0
+200.0(+8.70%)
Closed·
Unusual trading volume
Earnings results expected in 0 days
4886 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,311.02,540.0
52 wk Range
1,825.02,942.0
Key Statistics
Bid/Ask
2,485.00 / 2,498.00
Prev. Close
2,298
Open
2,344
Day's Range
2,311-2,540
52 wk Range
1,825-2,942
Volume
857.3K
Average Volume (3m)
88.96K
1-Year Change
27.514%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4886 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2,500.0
Upside
+0.08%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

ASKA Pharmaceutical Holdings Co Ltd Company Profile

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Employees
1632
Market
Japan

Compare 4886 to Peers and Sector

Metrics to compare
4886
Peers
Sector
Relationship
P/E Ratio
13.7x15.3x−0.6x
PEG Ratio
−0.670.230.00
Price/Book
1.0x1.0x2.6x
Price / LTM Sales
1.0x1.4x3.4x
Upside (Analyst Target)
8.8%8.3%44.4%
Fair Value Upside
Unlock9.7%6.1%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 2,500.0
(+0.08% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 168.05%
Dividend Yield
2.39%
Industry Median 2.35%
Annualised payout
55.00
Paid unevenly
5-Years Growth
+32.42%
Growth Streak

Earnings

Latest Release
Nov 04, 2025
EPS / Forecast
34.61 / --
Revenue / Forecast
15.93B / 16.03B
EPS Revisions
Last 90 days

4886 Income Statement

FAQ

What Stock Exchange Does ASKA Pharmaceutical Holdings Co Trade On?

ASKA Pharmaceutical Holdings Co is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for ASKA Pharmaceutical Holdings Co?

The stock symbol for ASKA Pharmaceutical Holdings Co is "4886."

What Is the ASKA Pharmaceutical Holdings Co Market Cap?

As of today, ASKA Pharmaceutical Holdings Co market cap is 70.25B.

What Is ASKA Pharmaceutical Holdings Co's Earnings Per Share (TTM)?

The ASKA Pharmaceutical Holdings Co EPS (TTM) is 168.05.

When Is the Next ASKA Pharmaceutical Holdings Co Earnings Date?

ASKA Pharmaceutical Holdings Co will release its next earnings report on 01 Feb 2026.

From a Technical Analysis Perspective, Is 4886 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ASKA Pharmaceutical Holdings Co Stock Split?

ASKA Pharmaceutical Holdings Co has split 0 times.

How Many Employees Does ASKA Pharmaceutical Holdings Co Have?

ASKA Pharmaceutical Holdings Co has 1632 employees.

What is the current trading status of ASKA Pharmaceutical Holdings Co (4886)?

As of 30 Jan 2026, ASKA Pharmaceutical Holdings Co (4886) is trading at a price of 2,498.0, with a previous close of 2,298.0. The stock has fluctuated within a day range of 2,311.0 to 2,540.0, while its 52-week range spans from 1,825.0 to 2,942.0.

What Is ASKA Pharmaceutical Holdings Co (4886) Price Target According to Analysts?

The average 12-month price target for ASKA Pharmaceutical Holdings Co is JPY2,500.0, with a high estimate of JPY2500 and a low estimate of JPY2500. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +0.08% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.